HARVARD CAPITAL Group

Completed Deals

Harvard Capital enjoys extraordinary access to key decision makers in target firms, and has broad industry exposure.

_________________

Harvard Capital enjoys extraordinary access to key decision makers within the institutional investor community. Below is a partial list of entities that have invested in our client companies:

- - - Aisling Capital
    - Altitude Life Science Ventures
    - Arcadia Venture Partners
    - ARCH Venture Fund
    - BioAdvance Ventures
    - Biotechnology Development Fund
    - Boston Millennia
    - Canaan Equity
    - De Novo Ventures
    - Domain Associates
    - Easton Associates
    - Forward Ventures
    - Garner Investments
    - General Electric Pension Trust
    - Hambrecht & Quist
    - Hale Biopharma Ventures
    - Hamilton Apex Technology
    - InterWest Partners
    - InterWest Partners
    - Johnson & Johnson Development Corporation
    - Latterell Venture Partners
    - Mirabaud & Cie
    - Montagu Newhall
    - Montreux Equity Partners
    - NEA Ventures
    - New Enterprise Associates
    - New Leaf Ventures
    - Nomura International
    - Peninsula Equity Partners
    - Phoenix Life Insurance Company
    - PolyTechnos Venture Fund
    - Prism Venture Partners
    - Prospect Venture Partners
    - Quaker Bio Ventures
    - Quantum Technology
    - S.R. One
    - Skyline Ventures
    - SouthPointe Ventures
    - Strategic Advisors Fund
    - Versant Ventures
    - Vulcan Capital
    - Wasatch Venture Fund
    - Windamere Capital Ventures

Below is a partial list of past HCG clients:

- - - Airline Coach Services
    - Artemis Innovations (Soap)
    - Babcock & Wilcox Company
    - Bio-ID Diagnostics
    - BiPar Sciences
    - Carticept Medical
    - Computer Sciences Corporation (TXENet)
    - EvokePharma
    - First Tangible Assets
    - H.T.E.
    - Hammes Group
    - HQ Global Workplaces
    - Hvide Marine
    - Industrial Printing Group
    - Inspiration Medical
    - Intira Corporation
    - Kythera Biopharmaceuticals
    - Maitland Primrose Group
    - NovaCardia
    - NovaDigm Therapeutics
    - Novalar Pharmaceuticals
    - Nuon Pharmaceuticals
    - OmniSonics Medical Devices
    - Planet Technologies
    - SalonCity
    - Sequel Pharmaceuticals
    - TargetRx
    - TransOral Pharmaceuticals
    - Valley Cab
    - Vialog Corporation
    - Woodford Technologies (Patersons)
    - Yurosek Farms

Below is a partial list deals previously worked on by HCG principals:

- - - Acro Healthcare, LLC acquired by Lincare, Inc. (public company)
    - First Republic Bank (IPO)
    - Carver Bankcorp (PIPE)

Aisling Capital
Altitude Life Science Ventures
Arcadia Venture Partners
ARCH Venture Fund
BioAdvance Ventures
Biotechnology Development Fund
Boston Millennia
Canaan Equity
De Novo Ventures
Domain Associates
Easton Associates
Forward Ventures
Garner Investments
General Electric Pension Trust
Hambrecht & Quist
Hale Biopharma Ventures
Hamilton Apex Technology
InterWest Partners
InterWest Partners
Johnson & Johnson Development Corporation
Latterell Venture Partners
Mirabaud & Cie
Montagu Newhall
Montreux Equity Partners
NEA Ventures
New Enterprise Associates
New Leaf Ventures
Nomura International
Peninsula Equity Partners
Phoenix Life Insurance Company
PolyTechnos Venture Fund
Prism Venture Partners
Prospect Venture Partners
Quaker Bio Ventures
Quantum Technology
S.R. One
Skyline Ventures
SouthPointe Ventures
Strategic Advisors Fund
Versant Ventures
Vulcan Capital
Wasatch Venture Fund
Windamere Capital Ventures

Harvard Capital enjoys extraordinary access to key decision makers within the institutional investor community. Below is a partial list of entities that have invested in our client companies: